FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to the use of a multi-specific antibody or its antigen-binding fragment characterized in (I) specificity relatively to CD3 and (II) specificity relatively to cancer and/or tumor antigen that is associated with urothelial cell neoplasm, as well as to the use of a composition containing it and a kit for the treatment of the bladder neoplasm.
EFFECT: invention is effective for the treatment of urinary tract neoplasm, improves survival rate of patients suffering from urinary tract neoplasm and has a lower risk of side effects.
125 cl, 4 dwg, 9 tbl, 4 ex
| Title |
Year |
Author |
Number |
| COMBINATION CONTAINING MULTIFUNCTIONAL ANTIBODIES REDIRECTING T-CELLS AND CONTROL POINT MODULATORS, AND ITS APPLICATIONS |
2017 |
|
RU2773655C2 |
| ABX196 FOR USE IN TREATMENT OF BLADDER CANCER |
2018 |
- Crabe, Sandrine
- Scherrer, Didier
- Ehrlich, Hartmut
- Pouletty, Philippe
|
RU2778812C2 |
| CYTOTOXICITY-INDUCING THERAPEUTIC AGENT |
2011 |
- Nezu Yuniti
- Isigiro Takakhiro
- Narita Atsusi
- Sakamoto Akisa
- Kavai Yumiko
- Igava Tomoyuki
- Karamoti Taiti
|
RU2663123C2 |
| USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND PSMA AND CD3, IN COMBINATION WITH COSTIMULATION 4-1BB |
2020 |
- Kirshner, Dzhessika R.
- Krouford, Elison
- Chiu, Danika
|
RU2822092C2 |
| PSCAXCD3, CD19XCD3, C-METXCD3, ENDOSIALIN XCD3, EPCAMXCD3, IGF-1RXCD3 OR FAP-ALPHA XCD3 BISPECIFIC SINGLE-CHAIN ANTIBODY WITH INTER-SPECIES SPECIFICITY |
2009 |
- Kufer,Peter
- Raum,Tobias
- Kischel,Roman
- Lutterbuse,Ralf
- Hoffmann,Patrick
- Rau,Doris
- Klinger,Matthias
- Mangold,Susanne
- Blumel,Claudia
|
RU2547600C2 |
| BISPECIFIC ANTIBODIES TO CD25 AND Fc GAMMA-RECEPTOR FOR ELIMINATION OF TUMOR-SPECIFIC CELLS |
2017 |
- Kezada, Serkhio
- Peggs, Karl
- Arse Vargas, Frederik
|
RU2759970C2 |
| THERAPY OF METASTATIC UROTHELIAL CANCER USING ANTIBODY-DRUG CONJUGATE SATSITUZUMAB GOVITECAN (IMMU-132) |
2017 |
- Govindan Serengulam V.
- Goldenberg David M.
|
RU2757395C2 |
| CELL DAMAGE INDUCING THERAPEUTIC MEDICINAL PRODUCT FOR ANTICANCER THERAPY |
2017 |
- Kinosita Yasuko
- Kavaj Yumiko
- Tsunenari Tosiaki
- Isiguro Takakhiro
- Endo Mika
- Sano Yudzi
|
RU2746754C2 |
| USE OF BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND MUC16 AND CD3, IN COMBINATION WITH COSTIMULATION 4-1BB |
2020 |
- Kirshner, Dzhessika R.
- Krouford, Elison
- Chiu, Danika
|
RU2822091C2 |
| ANTIBODIES TO HUMAN INTERLEUKIN-2 AND THEIR APPLICATION |
2018 |
- Surh, Charles D.
- Lee, Jun-Young
|
RU2745451C1 |
